{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:46:24Z","timestamp":1793533584405,"version":"4.5.0"},"reference-count":30,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,12,1]]},"abstract":"<jats:p>Objective. To correlate 3 common presenting signs of retinoblastoma with patient and ocular survival and to assess the efficacy of current pediatric screening practices for retinoblastoma.<\/jats:p>\n               <jats:p>Methods. A retrospective study was conducted of 1831 retinoblastoma patients from our center (1914\u2013June 2000). Patient survival (excluding deaths from other primary neoplasms) and ocular survival (presenting eyes) rates were calculated and analyzed using the Kaplan-Meier method.<\/jats:p>\n               <jats:p>Results. Leukocoria correlated with excellent patient survival (&amp;gt;86%, 5 years) but poor ocular survival in unilateral (4%, 5 years) and bilateral patients (29%, 5 years). A total of 308 (19%) of 1654 patients presented with strabismus: patient survival was excellent (90%, 5 years), and ocular survival was poor (17%, 5 years) yet better than leukocoria. Patients who had a family history of retinoblastoma and were clinically screened for retinal tumors from birth were diagnosed younger (8 months of age) and earlier (Reese Ellsworth group 1 = 26 [58%] of 45) and had better ocular survival than nonscreened patients with a family history. More patients were initially detected by family\/friends (1315 [80%] of 1632) than pediatricians (123 [8%] of 1632) or ophthalmologists (156 [10%] of 1632).<\/jats:p>\n               <jats:p>Conclusion. Most US children whose retinoblastoma is diagnosed initially present with leukocoria detected by a parent, despite routine pediatric screening for leukocoria via the red reflex test. Initial disease detection at the point of leukocoria or strabismus correlated with high patient survival rates and poor ocular survival rates for the presenting eye. Saving eyes and vision requires disease recognition before leukocoria, as demonstrated by the better ocular salvage rate among patients who had a positive family history and received clinical surveillance via early, routine dilated funduscopic examinations by an ophthalmologist.<\/jats:p>","DOI":"10.1542\/peds.112.6.1248","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"1248-1255","source":"Crossref","is-referenced-by-count":168,"title":["Screening for Retinoblastoma: Presenting Signs as Prognosticators of Patient and Ocular Survival"],"prefix":"10.1542","volume":"112","author":[{"given":"David H.","family":"Abramson","sequence":"first","affiliation":[{"name":"From the Robert M. Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital\u2013Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Beaverson","sequence":"additional","affiliation":[{"name":"From the Robert M. Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital\u2013Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poorab","family":"Sangani","sequence":"additional","affiliation":[{"name":"From the Robert M. Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital\u2013Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A.","family":"Vora","sequence":"additional","affiliation":[{"name":"From the Robert M. Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital\u2013Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Lee","sequence":"additional","affiliation":[{"name":"From the Robert M. Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital\u2013Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary M.","family":"Hochberg","sequence":"additional","affiliation":[{"name":"From the Robert M. Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital\u2013Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kirszrot","sequence":"additional","affiliation":[{"name":"From the Robert M. Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital\u2013Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murali","family":"Ranjithan","sequence":"additional","affiliation":[{"name":"From the Robert M. Ellsworth Ophthalmic Oncology Center, Department of Ophthalmology, New York Presbyterian Hospital\u2013Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2003,12,1]]},"reference":[{"key":"2021121003464817900_R1","unstructured":"Abramson DH, Dunkel IF, McCormick B. Neoplasms of the eye. In: Holland JF, Bast RL Jr, Morton DL, Frei E III, Kufe DW, Weichselbaum RR, eds. Cancer Medicine. 4th ed. Baltimore, MD: Williams & Wilkins; 1997: 1517\u20131536"},{"key":"2021121003464817900_R2","doi-asserted-by":"crossref","unstructured":"Chantada G, Fandino A, Manzitti J, Urrutia L, Schvartzman E. Late diagnosis of retinoblastomas in a developing country. Arch Dis Child.1999;80:171\u2013174","DOI":"10.1136\/adc.80.2.171"},{"key":"2021121003464817900_R3","doi-asserted-by":"crossref","unstructured":"Kodilinye HC. Retinoblastoma in Nigeria: problems of treatment. Am J Ophthalmol.1967;63:469\u2013481","DOI":"10.1016\/0002-9394(67)90246-2"},{"key":"2021121003464817900_R4","doi-asserted-by":"crossref","unstructured":"Schvartzman E, Chantada G, Fandino A, de Davila MT, Raslawski E, Manzitti J. Results of a stage-based approach for the treatment of retinoblastoma. J Clin Oncol.1996;14:1532\u20131536","DOI":"10.1200\/JCO.1996.14.5.1532"},{"key":"2021121003464817900_R5","unstructured":"Augsburger JJ, Bornfeld N, Giblin M. Malignant intraocular tumors\u2014retinoblastoma. In: Yanoff M, ed. Ophthalmology. 1st ed. St. Louis, MO: Mosby International; 1999: 9.2.1\u20139.2.8"},{"key":"2021121003464817900_R6","doi-asserted-by":"crossref","unstructured":"Tamboli A, Podger MJ, Horm JW. The incidence of retinoblastoma in the United States: 1974 through 1985. Arch Ophthalmol.1990;108:128\u2013132","DOI":"10.1001\/archopht.1990.01070030134045"},{"key":"2021121003464817900_R7","doi-asserted-by":"crossref","unstructured":"Polednak AP, Flannery JT. Brain, other central nervous system, and eye cancer. Cancer.1995;75:330\u2013337","DOI":"10.1002\/1097-0142(19950101)75:1+<330::AID-CNCR2820751315>3.0.CO;2-5"},{"key":"2021121003464817900_R8","doi-asserted-by":"crossref","unstructured":"Abramson DH, Ellsworth RM, Grumbach N, Sturgis-Buckhout L, Haik BG. Retinoblastoma: correlation between age at diagnosis and survival. Pediatr Ophthalmol Strabismus.1986;23:174\u2013177","DOI":"10.3928\/0191-3913-19860701-06"},{"key":"2021121003464817900_R9","doi-asserted-by":"crossref","unstructured":"Abramson DH, Frank CM, Susman M, Whalen MP, Dunkel I, Boyd NW III. Presenting signs of retinoblastoma. J Pediatr.1998;132:505\u2013508","DOI":"10.1016\/S0022-3476(98)70028-9"},{"key":"2021121003464817900_R10","unstructured":"Shields JA. Diagnosis and Management of Intraocular Tumors. St. Louis, MO: CV Mosby; 1983: 439"},{"key":"2021121003464817900_R11","doi-asserted-by":"crossref","unstructured":"Bedford MA, Bedetto C, Macfaul PA. Retinoblastoma, a study of 139 patients. Br J Ophthalmol.1971;55:19\u201327","DOI":"10.1136\/bjo.55.1.19"},{"key":"2021121003464817900_R12","doi-asserted-by":"crossref","unstructured":"Balmer A, Gailloud C. Retinoblastoma: Diagnosis and treatment. Including a clinical study. In: Straub W, ed. Turning Points in Cataract Formation, Syndromes, and Retinoblastoma. New York, NY: Karger; 1983: 36\u2013100","DOI":"10.1159\/000407310"},{"key":"2021121003464817900_R13","doi-asserted-by":"crossref","unstructured":"Tarkkanen A, Tuovinen E. Retinoblastoma in Finland 1912\u20131964. Acta Ophthalmol.1971;49:293\u2013300","DOI":"10.1111\/j.1755-3768.1971.tb00953.x"},{"key":"2021121003464817900_R14","unstructured":"Ellsworth RM. Retinoblastoma: an overview. Contemp Iss Ophthalmol.1986;2:1\u201310"},{"key":"2021121003464817900_R15","doi-asserted-by":"crossref","unstructured":"Abramson, DH, Gombos DS. The topography of bilateral retinoblastoma lesions. Retina.1996;16:232\u2013239","DOI":"10.1097\/00006982-199616030-00009"},{"key":"2021121003464817900_R16","unstructured":"Mahoney DH. Retinoblastoma. In: McMillan JA, ed. Oski\u2019s Pediatrics: Principles and Practice. New York, NY: Lippincott Williams & Wilkins; 1999: 1525\u20131527"},{"key":"2021121003464817900_R17","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Practice and Ambulatory Medicine, Section on Ophthalmology. Eye examination and vision screening in infants, children, and young adults. Pediatrics.1996;98:153\u2013157","DOI":"10.1542\/peds.98.1.153"},{"key":"2021121003464817900_R18","unstructured":"American Academy of Pediatrics, Committee on Practice and Ambulatory Medicine. Recommendations for preventative pediatric health care. Pediatrics.1995;96:373\u2013374"},{"key":"2021121003464817900_R19","unstructured":"American Academy of Ophthalmology. Pediatric Eye Evaluations, Preferred Practice Pattern. San Francisco, CA: American Academy of Ophthalmology; 1997: 1\u201317"},{"key":"2021121003464817900_R20","unstructured":"Division of Child Health Research. Periodic Survey of Fellows #22: Vision screening practices of pediatricians. Executive Summary. American Academy of Pediatrics; 1993. Available at: www.aap.org\/research\/ps22ex2.htm"},{"key":"2021121003464817900_R21","doi-asserted-by":"crossref","unstructured":"Wall TC, Marsh-Tootle W, Evans HH, Fargason CA, Ashworth CS, Hardin JM. Compliance with vision-screening guidelines among a national sample of pediatricians. Ambul Pediatr.2002;2:449\u2013455","DOI":"10.1367\/1539-4409(2002)002<0449:CWVSGA>2.0.CO;2"},{"key":"2021121003464817900_R22","unstructured":"Ellsworth RM. Management of retinoblastoma. Trans Am Ophthalmol Soc.1969;67:463\u2013534"},{"key":"2021121003464817900_R23","doi-asserted-by":"crossref","unstructured":"Byrd RS, Hoekelman RA, Auinger MA. Adherence to AAP guidelines for well-child care under managed care. Pediatrics.1999;104:536\u2013540","DOI":"10.1542\/peds.104.3.536"},{"key":"2021121003464817900_R24","doi-asserted-by":"crossref","unstructured":"Canzano JC, Handa JT. Utility of pupillary dilation for detecting leukocoria in patients with retinoblastoma. Pediatrics.1999;104(4). Available at: pediatrics.aappublications.org\/cgi\/content\/full\/104\/4\/e44","DOI":"10.1542\/peds.104.4.e44"},{"key":"2021121003464817900_R25","doi-asserted-by":"crossref","unstructured":"Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A.1971;68:820\u2013823","DOI":"10.1073\/pnas.68.4.820"},{"key":"2021121003464817900_R26","doi-asserted-by":"crossref","unstructured":"Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst.1993;85:1121\u20131128","DOI":"10.1093\/jnci\/85.14.1121"},{"key":"2021121003464817900_R27","doi-asserted-by":"crossref","unstructured":"Abramson DH, Mendelsohn ME, Servodidio CA, Tretter T, Gombos DS. Familial retinoblastoma: where and when?Acta Ophthalmol Scand.1998;76:334\u2013338","DOI":"10.1034\/j.1600-0420.1998.760316.x"},{"key":"2021121003464817900_R28","doi-asserted-by":"crossref","unstructured":"Goddard AG, Kingston JE, Hungerford JL. Delay in diagnosis of retinoblastoma: risk factors and treatment outcome. Br J Ophthalmol.1999;83:1320\u20131323","DOI":"10.1136\/bjo.83.12.1320"},{"key":"2021121003464817900_R29","doi-asserted-by":"crossref","unstructured":"DerKinderen DJ, Koten JW, Nagelkerke NJD, et al. Early diagnosis of bilateral retinoblastoma reduces death and blindness. Int J Cancer.1989;44:35\u201339","DOI":"10.1002\/ijc.2910440107"},{"key":"2021121003464817900_R30","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Section on Ophthalmology. Red reflex examinations in infants. Pediatrics.2002;109:980\u2013981","DOI":"10.1542\/peds.109.5.980"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/6\/1248\/1102493\/zpe01203001248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/112\/6\/1248\/1102493\/zpe01203001248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T11:00:50Z","timestamp":1639134050000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/112\/6\/1248\/63555\/Screening-for-Retinoblastoma-Presenting-Signs-as"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12,1]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2003,12,1]]},"published-print":{"date-parts":[[2003,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.112.6.1248","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,12,1]]}}}